Results 141 to 150 of about 18,687 (179)

Replication Stress in Cancer: Mechanistic Insights and Therapeutic Opportunities for Radiosensitization. [PDF]

open access: yesCurr Issues Mol Biol
Vasilopoulos SN   +6 more
europepmc   +1 more source

Biophysical radiosensitization

Radiation and Environmental Biophysics, 1983
Experimental studies on normal and tumor-bearing rats revealed that chronic treatment with hydroquinone (5 mg/kg/day) inhibited catalase activity in liver, spleen, blood, and H 18R tumor. 3H-hydroquinone (1.5 microCi/g body weight) showed tumor specificity, with maximum radioactivity in the tumor at 1 h after administration. The biological half-time of
C, Vladescu, M, Apetroae
openaire   +2 more sources

Antimetabolite Radiosensitizers

Journal of Clinical Oncology, 2007
Radiosensitization with antimetabolites has improved clinical outcome for patients with solid malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil (FU) and hydroxyurea have been widely used clinically during the last four decades, and promising results have been observed more recently with gemcitabine. Although the
Donna S, Shewach, Theodore S, Lawrence
openaire   +2 more sources

Cancer Radiosensitizers

Trends in Pharmacological Sciences, 2018
Radiotherapy (RT) is a mainstay treatment for many types of cancer, although it is still a large challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are promising agents that enhance injury to tumor tissue by accelerating DNA damage and producing free radicals.
Hao, Wang   +3 more
openaire   +2 more sources

Care with radiosensitizers

The British Journal of Radiology, 1979
Hendry and Sutton (1978) express concern about the possible sensitizing effect of misonidazole in normal tissues in patients treated with this drug combined with radiotherapy. Their argument is based upon the enhanced effect seen in human normal tissues following treatment in hyperbaric oxygen and upon observations in animals when radiotherapy is ...
G E, Adams, S, Dische
openaire   +2 more sources

Organelle-localized radiosensitizers

Chemical Communications, 2020
This feature article highlights the recent advances of organelle-localized radiosensitizers and discusses the current challenges and future directions.
Yuanyuan Chen   +5 more
openaire   +2 more sources

[Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].

Gan no rinsho. Japan journal of cancer clinics, 1991
Because of the unsuccessful clinical trials of misonidazole (MISO), many efforts have been made to find a new hypoxic cell sensitizer which is more effective and/or less toxic than MISO. In Japan, RK-28 is already under going Phase II clinical evaluation and RP-170, KU-2285 and KIH-802 have been proven to be effective both in vitro and in vivo and are ...
C, Murayama, T, Mori
openaire   +1 more source

Modifiers of radiosensitivity

Experientia, 1989
Many different methods exist by which the radiosensitivity of cells, and hence of normal tissues and tumours, can be manipulated. Several of these can be traced to a common redox pathway involving competition between oxidising and reducing species. Others involve the biochemical enzyme systems required for removal of DNA lesions.
A, Rojas, J, Denekamp
openaire   +2 more sources

Home - About - Disclaimer - Privacy